 | • レポートコード：MRC2-11QY13292 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は全細胞コレラワクチンのグローバル市場について調査・分析したレポートです。種類別（大人用、子供用）市場規模、用途別（臨床研究所、病院、外科センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別全細胞コレラワクチンの競争状況、市場シェア ・世界の全細胞コレラワクチン市場：種類別市場規模 2015年-2020年（大人用、子供用） ・世界の全細胞コレラワクチン市場：種類別市場規模予測 2021年-2026年（大人用、子供用） ・世界の全細胞コレラワクチン市場：用途別市場規模 2015年-2020年（臨床研究所、病院、外科センター、その他） ・世界の全細胞コレラワクチン市場：用途別市場規模予測 2021年-2026年（臨床研究所、病院、外科センター、その他） ・北米の全細胞コレラワクチン市場分析：米国、カナダ ・ヨーロッパの全細胞コレラワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの全細胞コレラワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の全細胞コレラワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの全細胞コレラワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：SBL Vaccine、PaxVax、Valneva SE、GlaxoSmithKline、Johnson and Johnson、Merck、Pfizer、Sanofi Pasteur、AstraZeneca(Medimmune, LLC.)、Serum Institute of India ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Whole Cell Cholera Vaccine is used to prevent Cholera.
The factors that fuel the growth of the global whole cell cholera vaccine (recombinant B-subunit) market are rising incidence of cholera among people in endemic regions along with a lack of sanitation and hygiene in certain countries.
Market Analysis and Insights: Global Whole Cell Cholera Vaccine Market
The global Whole Cell Cholera Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Whole Cell Cholera Vaccine Scope and Market Size
Whole Cell Cholera Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Whole Cell Cholera Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Whole Cell Cholera Vaccine market is segmented into
For Adults
For Children
Segment by Application, the Whole Cell Cholera Vaccine market is segmented into
Clinical Research Institutes
Hospital
Surgical Centers
Others
Regional and Country-level Analysis
The Whole Cell Cholera Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Whole Cell Cholera Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Whole Cell Cholera Vaccine Market Share Analysis
Whole Cell Cholera Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Whole Cell Cholera Vaccine business, the date to enter into the Whole Cell Cholera Vaccine market, Whole Cell Cholera Vaccine product introduction, recent developments, etc.
The major vendors covered:
SBL Vaccine
PaxVax
Valneva SE
GlaxoSmithKline
Johnson and Johnson
Merck
Pfizer
Sanofi Pasteur
AstraZeneca(Medimmune, LLC.)
Serum Institute of India
1 Study Coverage
1.1 Whole Cell Cholera Vaccine Product Introduction
1.2 Market Segments
1.3 Key Whole Cell Cholera Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Whole Cell Cholera Vaccine Market Size Growth Rate by Type
1.4.2 For Adults
1.4.3 For Children
1.5 Market by Application
1.5.1 Global Whole Cell Cholera Vaccine Market Size Growth Rate by Application
1.5.2 Clinical Research Institutes
1.5.3 Hospital
1.5.4 Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Whole Cell Cholera Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Whole Cell Cholera Vaccine Revenue 2015-2026
2.1.2 Global Whole Cell Cholera Vaccine Sales 2015-2026
2.2 Global Whole Cell Cholera Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Whole Cell Cholera Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Whole Cell Cholera Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Whole Cell Cholera Vaccine Competitor Landscape by Players
3.1 Whole Cell Cholera Vaccine Sales by Manufacturers
3.1.1 Whole Cell Cholera Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Whole Cell Cholera Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Whole Cell Cholera Vaccine Revenue by Manufacturers
3.2.1 Whole Cell Cholera Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Whole Cell Cholera Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Whole Cell Cholera Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Whole Cell Cholera Vaccine Revenue in 2019
3.2.5 Global Whole Cell Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Whole Cell Cholera Vaccine Price by Manufacturers
3.4 Whole Cell Cholera Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Whole Cell Cholera Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Whole Cell Cholera Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Whole Cell Cholera Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Whole Cell Cholera Vaccine Market Size by Type (2015-2020)
4.1.1 Global Whole Cell Cholera Vaccine Sales by Type (2015-2020)
4.1.2 Global Whole Cell Cholera Vaccine Revenue by Type (2015-2020)
4.1.3 Whole Cell Cholera Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Whole Cell Cholera Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Whole Cell Cholera Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Whole Cell Cholera Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Whole Cell Cholera Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Whole Cell Cholera Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Whole Cell Cholera Vaccine Market Size by Application (2015-2020)
5.1.1 Global Whole Cell Cholera Vaccine Sales by Application (2015-2020)
5.1.2 Global Whole Cell Cholera Vaccine Revenue by Application (2015-2020)
5.1.3 Whole Cell Cholera Vaccine Price by Application (2015-2020)
5.2 Whole Cell Cholera Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Whole Cell Cholera Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Whole Cell Cholera Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Whole Cell Cholera Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Whole Cell Cholera Vaccine by Country
6.1.1 North America Whole Cell Cholera Vaccine Sales by Country
6.1.2 North America Whole Cell Cholera Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Whole Cell Cholera Vaccine Market Facts & Figures by Type
6.3 North America Whole Cell Cholera Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Whole Cell Cholera Vaccine by Country
7.1.1 Europe Whole Cell Cholera Vaccine Sales by Country
7.1.2 Europe Whole Cell Cholera Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Whole Cell Cholera Vaccine Market Facts & Figures by Type
7.3 Europe Whole Cell Cholera Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Whole Cell Cholera Vaccine by Region
8.1.1 Asia Pacific Whole Cell Cholera Vaccine Sales by Region
8.1.2 Asia Pacific Whole Cell Cholera Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Whole Cell Cholera Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Whole Cell Cholera Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Whole Cell Cholera Vaccine by Country
9.1.1 Latin America Whole Cell Cholera Vaccine Sales by Country
9.1.2 Latin America Whole Cell Cholera Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Whole Cell Cholera Vaccine Market Facts & Figures by Type
9.3 Central & South America Whole Cell Cholera Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Whole Cell Cholera Vaccine by Country
10.1.1 Middle East and Africa Whole Cell Cholera Vaccine Sales by Country
10.1.2 Middle East and Africa Whole Cell Cholera Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Whole Cell Cholera Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Whole Cell Cholera Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 SBL Vaccine
11.1.1 SBL Vaccine Corporation Information
11.1.2 SBL Vaccine Description and Business Overview
11.1.3 SBL Vaccine Sales, Revenue and Gross Margin (2015-2020)
11.1.4 SBL Vaccine Whole Cell Cholera Vaccine Products Offered
11.1.5 SBL Vaccine Related Developments
11.2 PaxVax
11.2.1 PaxVax Corporation Information
11.2.2 PaxVax Description and Business Overview
11.2.3 PaxVax Sales, Revenue and Gross Margin (2015-2020)
11.2.4 PaxVax Whole Cell Cholera Vaccine Products Offered
11.2.5 PaxVax Related Developments
11.3 Valneva SE
11.3.1 Valneva SE Corporation Information
11.3.2 Valneva SE Description and Business Overview
11.3.3 Valneva SE Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Valneva SE Whole Cell Cholera Vaccine Products Offered
11.3.5 Valneva SE Related Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Description and Business Overview
11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline Whole Cell Cholera Vaccine Products Offered
11.4.5 GlaxoSmithKline Related Developments
11.5 Johnson and Johnson
11.5.1 Johnson and Johnson Corporation Information
11.5.2 Johnson and Johnson Description and Business Overview
11.5.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Johnson and Johnson Whole Cell Cholera Vaccine Products Offered
11.5.5 Johnson and Johnson Related Developments
11.6 Merck
11.6.1 Merck Corporation Information
11.6.2 Merck Description and Business Overview
11.6.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck Whole Cell Cholera Vaccine Products Offered
11.6.5 Merck Related Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Description and Business Overview
11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Pfizer Whole Cell Cholera Vaccine Products Offered
11.7.5 Pfizer Related Developments
11.8 Sanofi Pasteur
11.8.1 Sanofi Pasteur Corporation Information
11.8.2 Sanofi Pasteur Description and Business Overview
11.8.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Pasteur Whole Cell Cholera Vaccine Products Offered
11.8.5 Sanofi Pasteur Related Developments
11.9 AstraZeneca(Medimmune, LLC.)
11.9.1 AstraZeneca(Medimmune, LLC.) Corporation Information
11.9.2 AstraZeneca(Medimmune, LLC.) Description and Business Overview
11.9.3 AstraZeneca(Medimmune, LLC.) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Products Offered
11.9.5 AstraZeneca(Medimmune, LLC.) Related Developments
11.10 Serum Institute of India
11.10.1 Serum Institute of India Corporation Information
11.10.2 Serum Institute of India Description and Business Overview
11.10.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Serum Institute of India Whole Cell Cholera Vaccine Products Offered
11.10.5 Serum Institute of India Related Developments
11.1 SBL Vaccine
11.1.1 SBL Vaccine Corporation Information
11.1.2 SBL Vaccine Description and Business Overview
11.1.3 SBL Vaccine Sales, Revenue and Gross Margin (2015-2020)
11.1.4 SBL Vaccine Whole Cell Cholera Vaccine Products Offered
11.1.5 SBL Vaccine Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Whole Cell Cholera Vaccine Market Estimates and Projections by Region
12.1.1 Global Whole Cell Cholera Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Whole Cell Cholera Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Whole Cell Cholera Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Whole Cell Cholera Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Whole Cell Cholera Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Whole Cell Cholera Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Whole Cell Cholera Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Whole Cell Cholera Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Whole Cell Cholera Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Whole Cell Cholera Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Whole Cell Cholera Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Whole Cell Cholera Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Whole Cell Cholera Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Whole Cell Cholera Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Whole Cell Cholera Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Whole Cell Cholera Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Whole Cell Cholera Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Whole Cell Cholera Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Whole Cell Cholera Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Whole Cell Cholera Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Whole Cell Cholera Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Whole Cell Cholera Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Whole Cell Cholera Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Whole Cell Cholera Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Whole Cell Cholera Vaccine Market Segments
Table 2. Ranking of Global Top Whole Cell Cholera Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Whole Cell Cholera Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of For Adults
Table 5. Major Manufacturers of For Children
Table 6. Global Whole Cell Cholera Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Whole Cell Cholera Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Whole Cell Cholera Vaccine Sales by Regions 2015-2020 (K Units)
Table 9. Global Whole Cell Cholera Vaccine Sales Market Share by Regions (2015-2020)
Table 10. Global Whole Cell Cholera Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Whole Cell Cholera Vaccine Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Whole Cell Cholera Vaccine Sales Share by Manufacturers (2015-2020)
Table 13. Global Whole Cell Cholera Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Whole Cell Cholera Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Whole Cell Cholera Vaccine as of 2019)
Table 15. Whole Cell Cholera Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Whole Cell Cholera Vaccine Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Whole Cell Cholera Vaccine Price (2015-2020) (USD/Unit)
Table 18. Whole Cell Cholera Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Whole Cell Cholera Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Whole Cell Cholera Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Whole Cell Cholera Vaccine Sales by Type (2015-2020) (K Units)
Table 23. Global Whole Cell Cholera Vaccine Sales Share by Type (2015-2020)
Table 24. Global Whole Cell Cholera Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Whole Cell Cholera Vaccine Revenue Share by Type (2015-2020)
Table 26. Whole Cell Cholera Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Whole Cell Cholera Vaccine Sales by Application (2015-2020) (K Units)
Table 28. Global Whole Cell Cholera Vaccine Sales Share by Application (2015-2020)
Table 29. North America Whole Cell Cholera Vaccine Sales by Country (2015-2020) (K Units)
Table 30. North America Whole Cell Cholera Vaccine Sales Market Share by Country (2015-2020)
Table 31. North America Whole Cell Cholera Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Whole Cell Cholera Vaccine Revenue Market Share by Country (2015-2020)
Table 33. North America Whole Cell Cholera Vaccine Sales by Type (2015-2020) (K Units)
Table 34. North America Whole Cell Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 35. North America Whole Cell Cholera Vaccine Sales by Application (2015-2020) (K Units)
Table 36. North America Whole Cell Cholera Vaccine Sales Market Share by Application (2015-2020)
Table 37. Europe Whole Cell Cholera Vaccine Sales by Country (2015-2020) (K Units)
Table 38. Europe Whole Cell Cholera Vaccine Sales Market Share by Country (2015-2020)
Table 39. Europe Whole Cell Cholera Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Whole Cell Cholera Vaccine Revenue Market Share by Country (2015-2020)
Table 41. Europe Whole Cell Cholera Vaccine Sales by Type (2015-2020) (K Units)
Table 42. Europe Whole Cell Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 43. Europe Whole Cell Cholera Vaccine Sales by Application (2015-2020) (K Units)
Table 44. Europe Whole Cell Cholera Vaccine Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Whole Cell Cholera Vaccine Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Whole Cell Cholera Vaccine Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Whole Cell Cholera Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Whole Cell Cholera Vaccine Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Whole Cell Cholera Vaccine Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Whole Cell Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Whole Cell Cholera Vaccine Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Whole Cell Cholera Vaccine Sales Market Share by Application (2015-2020)
Table 53. Latin America Whole Cell Cholera Vaccine Sales by Country (2015-2020) (K Units)
Table 54. Latin America Whole Cell Cholera Vaccine Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Whole Cell Cholera Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Whole Cell Cholera Vaccine Revenue Market Share by Country (2015-2020)
Table 57. Latin America Whole Cell Cholera Vaccine Sales by Type (2015-2020) (K Units)
Table 58. Latin America Whole Cell Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 59. Latin America Whole Cell Cholera Vaccine Sales by Application (2015-2020) (K Units)
Table 60. Latin America Whole Cell Cholera Vaccine Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Whole Cell Cholera Vaccine Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Whole Cell Cholera Vaccine Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Whole Cell Cholera Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Whole Cell Cholera Vaccine Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Whole Cell Cholera Vaccine Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Whole Cell Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Whole Cell Cholera Vaccine Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Whole Cell Cholera Vaccine Sales Market Share by Application (2015-2020)
Table 69. SBL Vaccine Corporation Information
Table 70. SBL Vaccine Description and Major Businesses
Table 71. SBL Vaccine Whole Cell Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. SBL Vaccine Product
Table 73. SBL Vaccine Recent Development
Table 74. PaxVax Corporation Information
Table 75. PaxVax Description and Major Businesses
Table 76. PaxVax Whole Cell Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. PaxVax Product
Table 78. PaxVax Recent Development
Table 79. Valneva SE Corporation Information
Table 80. Valneva SE Description and Major Businesses
Table 81. Valneva SE Whole Cell Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Valneva SE Product
Table 83. Valneva SE Recent Development
Table 84. GlaxoSmithKline Corporation Information
Table 85. GlaxoSmithKline Description and Major Businesses
Table 86. GlaxoSmithKline Whole Cell Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. GlaxoSmithKline Product
Table 88. GlaxoSmithKline Recent Development
Table 89. Johnson and Johnson Corporation Information
Table 90. Johnson and Johnson Description and Major Businesses
Table 91. Johnson and Johnson Whole Cell Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Johnson and Johnson Product
Table 93. Johnson and Johnson Recent Development
Table 94. Merck Corporation Information
Table 95. Merck Description and Major Businesses
Table 96. Merck Whole Cell Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Merck Product
Table 98. Merck Recent Development
Table 99. Pfizer Corporation Information
Table 100. Pfizer Description and Major Businesses
Table 101. Pfizer Whole Cell Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Pfizer Product
Table 103. Pfizer Recent Development
Table 104. Sanofi Pasteur Corporation Information
Table 105. Sanofi Pasteur Description and Major Businesses
Table 106. Sanofi Pasteur Whole Cell Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Sanofi Pasteur Product
Table 108. Sanofi Pasteur Recent Development
Table 109. AstraZeneca(Medimmune, LLC.) Corporation Information
Table 110. AstraZeneca(Medimmune, LLC.) Description and Major Businesses
Table 111. AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. AstraZeneca(Medimmune, LLC.) Product
Table 113. AstraZeneca(Medimmune, LLC.) Recent Development
Table 114. Serum Institute of India Corporation Information
Table 115. Serum Institute of India Description and Major Businesses
Table 116. Serum Institute of India Whole Cell Cholera Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Serum Institute of India Product
Table 118. Serum Institute of India Recent Development
Table 119. Global Whole Cell Cholera Vaccine Sales Forecast by Regions (2021-2026) (K Units)
Table 120. Global Whole Cell Cholera Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Whole Cell Cholera Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Whole Cell Cholera Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Whole Cell Cholera Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 124. North America: Whole Cell Cholera Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Whole Cell Cholera Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 126. Europe: Whole Cell Cholera Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Whole Cell Cholera Vaccine Sales Forecast by Region (2021-2026) (K Units)
Table 128. Asia Pacific: Whole Cell Cholera Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Whole Cell Cholera Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 130. Latin America: Whole Cell Cholera Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Whole Cell Cholera Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 132. Middle East and Africa: Whole Cell Cholera Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Whole Cell Cholera Vaccine Players
Table 137. Whole Cell Cholera Vaccine Customers List
Table 138. Whole Cell Cholera Vaccine Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Whole Cell Cholera Vaccine Product Picture
Figure 2. Global Whole Cell Cholera Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. For Adults Product Picture
Figure 4. For Children Product Picture
Figure 5. Global Whole Cell Cholera Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Clinical Research Institutes
Figure 7. Hospital
Figure 8. Surgical Centers
Figure 9. Others
Figure 10. Whole Cell Cholera Vaccine Report Years Considered
Figure 11. Global Whole Cell Cholera Vaccine Market Size 2015-2026 (US$ Million)
Figure 12. Global Whole Cell Cholera Vaccine Sales 2015-2026 (K Units)
Figure 13. Global Whole Cell Cholera Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Whole Cell Cholera Vaccine Sales Market Share by Region (2015-2020)
Figure 15. Global Whole Cell Cholera Vaccine Sales Market Share by Region in 2019
Figure 16. Global Whole Cell Cholera Vaccine Revenue Market Share by Region (2015-2020)
Figure 17. Global Whole Cell Cholera Vaccine Revenue Market Share by Region in 2019
Figure 18. Global Whole Cell Cholera Vaccine Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Whole Cell Cholera Vaccine Revenue in 2019
Figure 20. Whole Cell Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Whole Cell Cholera Vaccine Sales Market Share by Type (2015-2020)
Figure 22. Global Whole Cell Cholera Vaccine Sales Market Share by Type in 2019
Figure 23. Global Whole Cell Cholera Vaccine Revenue Market Share by Type (2015-2020)
Figure 24. Global Whole Cell Cholera Vaccine Revenue Market Share by Type in 2019
Figure 25. Global Whole Cell Cholera Vaccine Market Share by Price Range (2015-2020)
Figure 26. Global Whole Cell Cholera Vaccine Sales Market Share by Application (2015-2020)
Figure 27. Global Whole Cell Cholera Vaccine Sales Market Share by Application in 2019
Figure 28. Global Whole Cell Cholera Vaccine Revenue Market Share by Application (2015-2020)
Figure 29. Global Whole Cell Cholera Vaccine Revenue Market Share by Application in 2019
Figure 30. North America Whole Cell Cholera Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Whole Cell Cholera Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Whole Cell Cholera Vaccine Sales Market Share by Country in 2019
Figure 33. North America Whole Cell Cholera Vaccine Revenue Market Share by Country in 2019
Figure 34. U.S. Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Whole Cell Cholera Vaccine Market Share by Type in 2019
Figure 39. North America Whole Cell Cholera Vaccine Market Share by Application in 2019
Figure 40. Europe Whole Cell Cholera Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Whole Cell Cholera Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Whole Cell Cholera Vaccine Sales Market Share by Country in 2019
Figure 43. Europe Whole Cell Cholera Vaccine Revenue Market Share by Country in 2019
Figure 44. Germany Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Whole Cell Cholera Vaccine Market Share by Type in 2019
Figure 55. Europe Whole Cell Cholera Vaccine Market Share by Application in 2019
Figure 56. Asia Pacific Whole Cell Cholera Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Whole Cell Cholera Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Whole Cell Cholera Vaccine Sales Market Share by Region in 2019
Figure 59. Asia Pacific Whole Cell Cholera Vaccine Revenue Market Share by Region in 2019
Figure 60. China Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Whole Cell Cholera Vaccine Market Share by Type in 2019
Figure 83. Asia Pacific Whole Cell Cholera Vaccine Market Share by Application in 2019
Figure 84. Latin America Whole Cell Cholera Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Whole Cell Cholera Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Whole Cell Cholera Vaccine Sales Market Share by Country in 2019
Figure 87. Latin America Whole Cell Cholera Vaccine Revenue Market Share by Country in 2019
Figure 88. Mexico Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Whole Cell Cholera Vaccine Market Share by Type in 2019
Figure 95. Latin America Whole Cell Cholera Vaccine Market Share by Application in 2019
Figure 96. Middle East and Africa Whole Cell Cholera Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Whole Cell Cholera Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Whole Cell Cholera Vaccine Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Whole Cell Cholera Vaccine Revenue Market Share by Country in 2019
Figure 100. Turkey Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Whole Cell Cholera Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Whole Cell Cholera Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Whole Cell Cholera Vaccine Market Share by Type in 2019
Figure 107. Middle East and Africa Whole Cell Cholera Vaccine Market Share by Application in 2019
Figure 108. North America Whole Cell Cholera Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Whole Cell Cholera Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Whole Cell Cholera Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Whole Cell Cholera Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Whole Cell Cholera Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Whole Cell Cholera Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Whole Cell Cholera Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Whole Cell Cholera Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Whole Cell Cholera Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Whole Cell Cholera Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
糖衣錠キャンディー（サル肝細胞）ポリオミセテスワクチンの世界市場（～2026年） Poliomycetes vaccine in Dragee Candy (monkey liver cell), live employs live but attenuated causative virus of polio. It is used as a preventive vaccine in children against polio virus. Market Analysis and Insights: Global Poliomycetes Vaccine in Dragee Candy (Monkey Liver Cell) Market The global Pol…- 経口ワクチンの世界市場（～2026年） Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery …
- mRNAワクチンの世界市場（～2026年） mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically wh…
- ヒト狂犬病ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Human Rabies Vaccine Market The global Human Rabies Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Rabies Vaccine Scope and Market Size Human Rabies Vaccine market is…
- 結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …